Protein patterns - a new tool for studying sepsis
1/13/2016
Sepsis is a very complicated and precarious condition. Research groups in Lund and Zurich have now developed a way to use mass spectrometry to measure hundreds of proteins in a single blood sample.
Does high folic acid intake reduce immune system defenses?
1/13/2016
A new study conducted in mice suggests that excess folic acid intake could impair specific immune cells, leaving them vulnerable to infections and cancer.
Why prostate cancer is more aggressive in obese patients
1/13/2016
Obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known.
Microlin Bio, Inc. announces publication of results from Antimir21 lung cancer study
1/13/2016
Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, has announced that results from a study demonstrating the...
Colorectal cancer more likely to affect minorities at younger age
1/13/2016
Colorectal cancer is the third most common form of cancer and the second most common cause of cancer deaths in the United States. The chance of developing colorectal cancer increases with age.
SCAI releases expert consensus for cardio-oncology patients treated in cardiac catheterization labs
1/13/2016
The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement providing cardiologists, oncologists and internal medicine physicians guidance for...
Neils help removing epigenetic marks
1/13/2016
Scientists at the Institute of Molecular Biology (IMB) in Mainz have identified a missing piece of the puzzle in understanding how epigenetic marks are removed from DNA.
Pomalidomide in multiple myeloma: No hints of added benefit
1/13/2016
Drug manufacturer dossier provided no suitable data for the assessment.Pomalidomide (trade name: Imnovid) has been approved since 2013 for the treatment of multiple myeloma that has returned and...
Scientists re-engineer body's immune system for safer and more effective cancer treatment
1/13/2016
Scientists have demonstrated a new way of re-engineering the body's immune system to target cancer, paving the way for a new generation of drugs, unprecedented in safety and effectiveness.
Unravelling the causes of lymphoma an aggressive childhood cancer
1/13/2016
The origins of a type of aggressive childhood lymphoma have been found, giving hope that new drugs could be designed to prevent the disease coming back after treatment.